Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

New benzo(b)thiophenesulphonamide 1,1-dioxide derivatives induce a reactive oxygen species-mediated process of apoptosis in tumour cells

Oncogene volume 22, pages 3759–3769 (2003)Cite this article

Abstract

In this work, we describe the process of cell death induced by a series of new benzo(b)thiophenesulphonamide 1,1-dioxide derivatives (BTS) that have been selected as candidate antineoplastic drugs. Human leukaemic CCRF-CEM cells incubated with BTS undergo a typical apoptotic process that includes cell shrinkage, phosphatidylserine translocation to the cell surface, mitochondrial dysfunction, caspase activation, chromatin condensation and internucleosomal DNA degradation. Mitochondrial alterations included dissipation of the mitochondrial membrane potential, oxidation of the phospholipid cardiolipin, release of cytochrome c and uncoupling of the mitochondrial respiratory chain, leading to a decrease of the intracellular ATP pool. Activation of caspase-8, -9 and -3 takes place during BTS-induced apoptosis. Either the addition of the specific caspase-8 inhibitor Z-IETD-fmk, or the overexpression of the antiapoptotic protein Bcl-2 significantly prevented BTS-induced apoptosis, suggesting the involvement of both caspase-8-regulated and mitochondria-dependent signalling pathways in this process. BTS induce a significant increase in the production and accumulation of intracellular reactive oxygen species (ROS) that can be observed within minutes after drug addition. Moreover, cytochrome c release, caspase-3 activation and cell death can be completely abrogated by a previous incubation with the antioxidant N-acetyl-cysteine. These results suggest that ROS are essential mediators in BTS-induced apoptosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Alonso MM, Encio I, Martinez-Merino V, Gil M and Migliaccio M . (2001). Br. J. Cancer, 85, 1400–1402.

  • Boutonnat J, Barbier M, Muirhead K, Mousseau M, Grunwald D, Ronot X and Seigneurin D . (2000). Cytometry, 42, 50–60.

  • Bozolla JJ and Russell LD . (1992). Electron Microscopy. Jones, Bartlett (ed). Boston, MA.

    Google Scholar 

  • Buttke TM and Sandstrom PA . (1995). Free Radic. Res., 22, 389–397.

  • Costantini P, Jacotot E, Decaudin D and Kroemer G . (2000). J. Natl. Cancer Inst., 92, 1042–1053.

  • Cotter TG, Glynn JM, Echeverri F and Green DR . (1992). Anticancer Res., 12, 773–779.

  • Ferreira CG, Span SW, Peters GJ, Kruyt FA and Giaccone G . (2000) Cancer Res., 60, 7133–7141.

  • Green DR, Bissonnette RP and Cotter TG . (1994). Important Adv. Oncol., 37–52.

  • Green DR and Reed JC . (1998). Science, 281, 1309–1312.

  • Hartmann BL, Geley S, Loffler M, Hattmannstorfer R, Strasser-Wozak EM, Auer B and Kofler R . (1999). Oncogene, 18, 713–719.

  • Howbert JJ, Grossman CS, Crowell TA, Rieder BJ, Harper RW, Kramer KE, Tao EV, Aikins J, Poore GA, Rinzel SM, Grindey GB, Shaw WN and Todd GC . (1990). J. Med. Chem., 33, 2393–2407.

  • Huschtscha LI, Bartier WA, Ross CE and Tattersall MH . (1996). Br. J. Cancer, 73, 54–60.

  • Keller JN, Kindy MS, Holtsberg FW, St Clair DK, Yen HC, Germeyer A, Steiner SM, Bruce-Keller AJ, Hutchins JB and Mattson MP . (1998). J. Neurosci., 18, 687–697.

  • Kim PKM, Mahidhara R and Seol DW . (2001). Drug Res. Update, 4, 293–296.

  • Koren R, Rocker D, Kotestiano O, Liberman UA and Ravid A . (2000). J. Steroid Biochem. Mol. Biol., 73, 105–112.

  • Kroemer G and Reed JC . (2000). Nat. Med., 6, 513–519.

  • Li PF, Dietz R and von Harsdorf R . (1999). EMBO J., 18, 6027–6036.

  • Martin SJ, Green DR and Cotter TG . (1994). Trends Biochem. Sci., 19, 26–30.

  • Martinez-Merino V, Gri MS, Encio I, Migliaccio H and Arteaga C (2000). Benzo(b)tiophere Sulphonamid 1,1-dioxide derivatives and their use as antineoplastic agents, Patent No WO 00/63202.

  • Mossmann T . (1983). J. Immunol. Method, 65, 55–59.

  • Nomura K, Imai H, Koumura T and Nakagawa Y . (2001). Biol. Signals Recept., 10, 81–92.

  • Oridate N, Higuchi M, Suzuki S, Shroot B, Hong WK and Lotan R . (1997a). Int. J. Cancer, 70, 484–487.

  • Oridate N, Lotan D, Mitchell MF, Hong WK and Lotan R . (1995). J. Cell. Biochem. Suppl., 23, 80–86.

  • Oridate N, Suzuki S, Higuchi M, Mitchell MF, Hong WK and Lotan R . (1997b). J. Natl. Cancer Inst., 89, 1191–1198.

  • Phillips AC, Bates S, Ryan KM, Helin K and Vousden KH . (1997). Genes Dev., 11, 1853–1863.

  • Reed JC and Kroemer G . (2000). Cell Death Differ., 7, 1145.

  • Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seniff D and Boyd MR . (1988). Cancer Res., 48, 4827–4833.

  • Seki K, Yoshikawa H, Shiiki K, Hamada Y, Akamatsu N and Tasaka K . (2000). Chemother. Pharmacol., 45, 199–206.

  • Shapiro HM . (2000). Methods, 21, 271–279.

  • Skulachev VP . (1998). FEBS Lett., 423(3), 275–280.

  • Sosinski J, Thakar JH, Germain GS, Harwood FC and Houghton PJ . (1993). Biochem. Pharmacol., 45, 2135–2142.

  • Susin SA, Zamzami N and Kroemer G . (1998). Biochim. Biophys. Acta, 1366, 151–165.

  • Suzuki S, Higuchi M, Proske RJ, Oridate N, Hong WK and Lotan R . (1999). Oncogene, 18, 6380–6387.

  • Tang D, Lahti JM and Kidd VJ . (2000). J. Biol. Chem., 275, 9303–9307.

  • Taylor WR and Stark GR . (2001). Oncogene, 20, 35–43.

  • Umansky V, Ratter F, Lampel S, Bucur M, Schirrmacher V and Ushmorov A . (2001). Exp. Cell Res., 265, 274–282.

  • Umansky V, Rocha M, Breitkreutz R, Hehner S, Bucur M, Erbe N, Droge W and Ushmorov A . (2000). J. Cell Biochem., 78, 578–587.

  • Zamai L, Canonico B, Luchetti F, Ferri P, Melloni E, Guidotti L, Cappellini A, Cutroneo G, Vitale M and Papa S . (2001). Cytometry, 44, 57–64.

  • Zamzami N and Kroemer G . (2001). Nat. Rev. Mol. Cell. Biol., 2, 67–71.

  • Zamzami N, Marchetti P, Castedo M, Decaudin D, Macho A, Hirsch T, Susin SA, Petit PX, Mignotte B and Kroemer G . (1995). J. Exp. Med., 182, 367–377.

Download references

Author information

Authors and Affiliations

  1. Department of Health Sciences, Public University of Navarra, Avd Barañaín s/n, Pamplona, 31008, Spain

    M M Alonso, J Villar, I J Encío & M Migliaccio

  2. Department of Cell Biology, University of Basque Country, Barrio Sarriena s/n, Leioa, 31006, Spain

    A Asumendi

  3. Department of Applied Chemistry, Public University of Navarra, Campus de Arrosadía, Pamplona, 31013, Spain

    M J Gil & V Martínez-Merino

Authors
  1. M M Alonso
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Asumendi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J Villar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M J Gil
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. V Martínez-Merino
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. I J Encío
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M Migliaccio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M Migliaccio.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alonso, M., Asumendi, A., Villar, J. et al. New benzo(b)thiophenesulphonamide 1,1-dioxide derivatives induce a reactive oxygen species-mediated process of apoptosis in tumour cells. Oncogene 22, 3759–3769 (2003). https://doi.org/10.1038/sj.onc.1206435

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206435

Keywords

This article is cited by

Search

Advanced search

Quick links